ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Up 13.2% – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) traded up 13.2% during mid-day trading on Wednesday. The stock traded as high as $12.49 and last traded at $12.21. 160,588 shares were traded during mid-day trading, a decline of 27% from the average session volume of 220,943 shares. The stock had previously closed at $10.79.

Analysts Set New Price Targets

CHRN has been the topic of several research reports. Weiss Ratings lowered ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Compass Point initiated coverage on ChronoScale Corporation Common Stock in a report on Friday, October 16th. They issued a “buy” rating and a $25.00 target price for the company. Finally, Northland Securities initiated coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an “outperform” rating and a $32.00 target price for the company. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, ChronoScale Corporation Common Stock presently has an average rating of “Hold” and a consensus price target of $21.00.

ChronoScale Corporation Common Stock Price Performance

The company has a 50-day moving average of $17.33 and a 200-day moving average of $16.09. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30. The stock has a market cap of $1.71 billion, a price-to-earnings ratio of -2.72 and a beta of 1.12.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The company had revenue of $41.48 million for the quarter. As a group, equities research analysts predict that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.